儿童期起病系统性红斑狼疮临床相关改善的ACR暂定标准
美国风湿病学会(ACR)组织213名儿童肾病与风湿病专家,通过国际共识会议定义儿童期起病系统性红斑狼疮(cSLE)的临床相关改善(CRIcSLE),并开发儿童狼疮改善指数(CHILI)。CHILI基于5项核心应答变量的绝对变化计算0–100分,≥54分识别CRIcSLE的AUC为0.93、敏感度81.1%、特异度84.2%。
要点
- CHILI总分≥54可判定cSLE临床相关改善,AUC 0.93。
- CHILI>15、>68、>92分别对应轻度、中度、重度改善。
- CHILI采用核心应答变量的绝对变化,经共识会议一致认可。
核心结论
- CHILI是测量cSLE随时间临床相关改善的新指数,可对治疗反应程度进行分级。
研究设计与样本
- 邀请213名有cSLE管理经验的儿童肾病与风湿病专家定义CRIcSLE,并对433份患者档案进行评级;由13名cSLE专家参加国际共识会议。
主要发现
- CHILI分值≥54识别CRIcSLE的AUC为0.93、敏感度81.1%、特异度84.2%。
- CHILI分值>15、>68、>92分别反映轻度、中度、重度改善,各项AUC≥0.92、敏感度≥93.1%、特异度≥73.4%。
关键数值与推荐
- 候选算法基于患者总体评估、医生总体评估、SLE疾病活动指数评分、尿蛋白/肌酐比值、Child Health Questionnaire躯体综合评分的百分比与绝对变化构建。
- 专家100%同意首选算法采用cSLE核心应答变量的绝对变化。
临床怎么用
- 临床可计算CHILI分值(0–100),以≥54判定临床相关改善,并按>15、>68、>92区分改善程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop a Childhood Lupus Improvement Index (CHILI) as a tool to measure response to therapy in childhood-onset systemic lupus erythematosus (cSLE), with a focus on clinically relevant improvement (CRIc SLE ). METHODS: Pediatric nephrology and rheumatology subspecialists (n = 213) experienced in cSLE management were invited to define CRIc SLE and rate a total of 433 unique patient profiles for the presence/absence of CRIc SLE . Patient profiles included the following cSLE core response variables (CRVs): global assessment of patient well-being (patient-global), physician assessment of cSLE activity (MD-global), disease activity index score (here, we used the Systemic Lupus Erythematosus Disease Activity Index), urine protein-to-creatinine ratio, and Child Health Questionnaire physical summary score. Percentage and absolute changes in these cSLE-CRVs (baseline versus follow-up) were considered in order to develop candidate algorithms and validate their performance (sensitivity, specificity, area under the receiver operating characteristic curve [AUC]; range 0-1). RESULTS: During an international consensus conference, unanimous agreement on a definition of CRIc SLE was achieved; cSLE experts (n = 13) concurred (100%) that the preferred CHILI algorithm considers absolute changes in the cSLE-CRVs. After transformation to a range of 0-100, a CHILI score of ≥54 had outstanding accuracy for identifying CRIc SLE (AUC 0.93, sensitivity 81.1%, and specificity 84.2%). CHILI scores also reflect minor, moderate, and major improvement for values exceeding 15, 68, and 92, respectively (all AUC ≥0.92, sensitivity ≥93.1%, and specificity ≥73.4%). CONCLUSION: The CHILI is a new, seemingly highly accurate index for measuring CRI in cSLE over time. This index is useful to categorize the degree of response to therapy in children and adolescents with cSLE.
引用
- Brunner HI, Holland MJ, Beresford MW, et al. American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2019. PMID: 30680946. doi:10.1002/acr.23834
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。